1315512-62-9

Basic information

• Product Name: 5-(3-chloropropoxy)-4-methoxy-2-aminobenzonitrile
• Synonyms: 5-(3-chloropropoxy)-4-methoxy-2-aminobenzonitrile
• CAS NO: 1315512-62-9
• Molecular Weight: 240.689
• Mol File: 1315512-62-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 5-(3-chloropropoxy)-4-methoxy-2-aminobenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(3-chloropropoxy)-4-methoxy-2-aminobenzonitrile(1315512-62-9)
• EPA Substance Registry System: 5-(3-chloropropoxy)-4-methoxy-2-aminobenzonitrile(1315512-62-9)

Safety Data

• Hazardous Substances Data: 1315512-62-9(Hazardous Substances Data)

Upstream product

• 52805-46-6 2-methoxy-5-cyanophenol 
• 621-59-0 isovanillin 
• 1315512-61-8 C₁₁H₁₁ClN₂O₄ 

Downstream Products

• 912556-91-3 6-(3-chloropropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-ylamine 
• 1437310-67-2 N-(3-ethynylphenyl)-6-(3-chloropropoxy)-7-methoxyquinazolin-4-amine 
• 1259017-73-6 N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(3-chloropropoxy)-7-methoxyquina-zolin-4-amine 

Relevant articles and documents

Synthesis and biological evaluation of selenogefitinib for reducing bleomycin-induced pulmonary fibrosis

Selenium has demonstrated effectiveness in the reduction of oxidative stress and inflammation in vitro and in vivo, both of which are key indicators of the pathogenesis of pulmonary fibrosis. Gefitinib, an FDA-approved EGFR inhibitor, effectively reverses

Novel 4-arylaminoquinazoline derivatives with (E)-propen-1-yl moiety as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells

A series of novel 4-anilinoquinazoline derivatives with (E)-propen-1-yl moiety were designed, synthesized and evaluated for biological activities in vitro. Most compounds exhibited highly antiproliferative activities against all tested tumor cell lines in